Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis.
Plasma cholesterol lowering (PCL) slows and sometimes prevents progression of atherosclerosis and may even lead to regression. Little is known about how molecular processes in the atherosclerotic arterial wall respond to PCL and modify responses to atherosclerosis regression. We studied atherosclero...
Guardado en:
Autores principales: | Johan L M Björkegren, Sara Hägg, Husain A Talukdar, Hassan Foroughi Asl, Rajeev K Jain, Cecilia Cedergren, Ming-Mei Shang, Aránzazu Rossignoli, Rabbe Takolander, Olle Melander, Anders Hamsten, Tom Michoel, Josefin Skogsberg |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91a3a9e28f764aec98649bad00f3c1b0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Regression of Atherosclerosis: Insights from Animal and Clinical Studies
por: Jonathan E. Feig
Publicado: (2014) -
ADAMTS-7 is associated with a high-risk plaque phenotype in human atherosclerosis
por: Eva Bengtsson, et al.
Publicado: (2017) -
Combined use of metformin and atorvastatin attenuates atherosclerosis in rabbits fed a high-cholesterol diet
por: Fei Luo, et al.
Publicado: (2017) -
Effect of Rhus Coriaria Consumption with High Cholesterol Food on Some Atherosclerosis Risk Factors in Rabbit
por: M Setorki, et al.
Publicado: (2012) -
Gene therapy in a humanized mouse model of familial hypercholesterolemia leads to marked regression of atherosclerosis.
por: Sadik H Kassim, et al.
Publicado: (2010)